Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1109448 NASHVILLE, TN
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$552,582
+$126,446 QoQ
Shares Held
37,900
+12.3% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. ENTA ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $552,582 37,900
2026-03-31 $426,136 33,740
2025-12-31 $532,079 33,740
2025-09-30 $403,867 33,740
2025-06-30 $255,074 33,740
2025-03-31 $165,268 29,940
2024-12-31 $172,155 29,940
2024-09-30 $310,178 29,940
2024-06-30 $388,321 29,940
2024-03-31 $487,657 27,930
2023-12-31 $262,821 27,930
2023-09-30 $342,583 30,670
2023-06-30 $475,294 22,210
2023-03-31 $790,197 19,540
2022-12-31 $1,042,745 22,415
2022-09-30 $2,646,874 51,029
2022-06-30 $5,965,663 126,204
2022-03-31 $7,881,690 110,729
2021-12-31 $4,475,882 59,854
2021-09-30 $1,320,832 23,250
2021-06-30 $1,128,856 25,650
2021-03-31 $1,265,058 25,650
2020-12-31 $1,076,497 25,570
2020-09-30 $1,170,594 25,570
2020-06-30 $1,463,119 29,140
2020-03-31 $1,498,670 29,140